Previous 10 | Next 10 |
2023-12-27 11:04:12 ET More on Consumer Staples XLP: Staples Turn Cheaper In 2023, Waiting On Improved Momentum The Consumer Staples Select Sector SPDR Fund ETF Is Due For A Massive Rebound XLP: I'd Rather Have Coal In My Stocking This is how consumer-specifi...
2023-12-14 12:28:56 ET Gainers: Freight Technologies ( FRGT ) +178% . TPI Composites ( TPIC ) +67% . TriSalus Life Sciences ( TLSI ) +35% . Codexis ( CDXS ) +33% . Canterbury Park Holding Corp ( CPHC ) +33% . Canaan ( CAN ...
2023-12-14 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Ocular Therape...
Mynd.ai, Inc. Consummates Merger Transaction PR Newswire SEATTLE , Dec. 13, 2023 /PRNewswire/ -- Mynd.ai, Inc. (" Mynd " or the " Company ") (NYSE: MYND), is pleased to announce the successful completion of the merger transaction (" Merger Transaction ...
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company committed to advancing treatments for patients coping with chronic and a...
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), We are delighted to announce the appointment of Mynd Life Sciences current CEO and Director, the Hon. Dr. Lyle Oberg, E.C.A., as the Boa...
Potential merger to create new industry leader. Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a pioneering biopharmaceutical research and development company dedicated to revolutionizing treatment...
MYND Life Sciences was formed to commercialize proprietary biomarker diagnostic tests and novel therapeutics for patients suffering from MDD, TRD and other neuro-inflammatory disorders Vancouver, British Columbia--(Newsfile Corp. - September 11, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQ...
Vancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - MYND Life Sciences ( CSE: MYND ) ( OTCQB: MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological di...
Vancouver, British Columbia--(Newsfile Corp. - April 12, 2023) - MYND Life Sciences (CSE: MYND ) (OTCQB: MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological...
News, Short Squeeze, Breakout and More Instantly...
Mynd Life Sciences Inc Com Company Name:
MYND Stock Symbol:
NASDAQ Market:
Mynd Life Sciences Inc Com Website:
Mynd Announces Fiscal Year 2023 Results PR Newswire Delivers Revenue of $413.6 Million and Successfully Completes Transformational Merger Transaction SEATTLE , March 27, 2024 /PRNewswire/ -- Mynd.ai, Inc. (the "Company" or "...
Promethean wins three Tech & Learning Awards of Excellence for 2023 Promethean wins three Tech & Learning Awards of Excellence for 2023 PR Newswire The company was recognized for its ActivPanel LX display, OPS-A computing module, and Explain Everything Advanced les...
Mynd.ai to Ring NYSE First Trade Bell on February 5th PR Newswire SEATTLE , Feb. 2, 2024 /PRNewswire/ -- Mynd.ai, Inc. ("Mynd" or the "Company") (NYSE American: MYND), today announced that Vin Riera , CEO, alongside members of Mynd's executive management team...